Angiodynamics (ANGO) Shares Outstanding (Diluted Average) (2016 - 2026)
Angiodynamics' Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $41.6 million for Q1 2026.
- For Q1 2026, Shares Outstanding (Diluted Average) rose 1.82% year-over-year to $41.6 million; the TTM value through Feb 2026 reached $41.6 million, up 1.82%, while the annual FY2025 figure was $40.9 million, 1.67% up from the prior year.
- Shares Outstanding (Diluted Average) reached $41.6 million in Q1 2026 per ANGO's latest filing, roughly flat from $41.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41.6 million in Q1 2026 to a low of $39.0 million in Q1 2022.
- Average Shares Outstanding (Diluted Average) over 5 years is $40.2 million, with a median of $40.1 million recorded in 2023.
- Peak YoY movement for Shares Outstanding (Diluted Average): increased 0.87% in 2022, then grew 1.88% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $39.4 million in 2022, then rose by 1.8% to $40.1 million in 2023, then rose by 1.71% to $40.8 million in 2024, then increased by 1.85% to $41.5 million in 2025, then rose by 0.13% to $41.6 million in 2026.
- Per Business Quant, the three most recent readings for ANGO's Shares Outstanding (Diluted Average) are $41.6 million (Q1 2026), $41.5 million (Q4 2025), and $41.2 million (Q3 2025).